##
##
##
|Paul Garvin|||Chairman
to 31stJanuary 2021||||||
|---|---|---|---|---|---|---|---|---|
|Neil Mundy|||Interim Joint Chairman
from 1stFebruary 2021 tc31stJuly 2021||||||
|Derek Bell|||Joint Chairman
from 1st September 2021||||||
|Julia Ann Gillon|||Chief Executive||||||
|Anandapuram|Deepak Dwarakanath||Medical Director /Deputy
Chief Executive||||||
|Alan Sheppard|||Chief People Officer||||||
|Neil Atkinson|||Director ofFinance||||||
|Julie Lane|||Director ofNursing,
Patient Safety|and Quality|to30th|November|2020||
|Graham
Evens
Lynne Taylor|||Chief Information
Technology
Offfcer
Director of Planning 6 Performance||||||
|Barbara Bright|||Director ofCorporate Affairs and Chief ofStaff||||||
|Levi Buckley|||Chief Operating
Officer||||||
|Stephen
Hall|||Vice Chairman
and Non-executive|Director|||||
|Rita Taylor|||Non-executive
Director||||||
|Jonathan
Erskine|||Non-executive
Director||||||
|Kevin Robinson|||Non-executive
Director||||||
|Philip Craig|||Nonwxecutive
Director||||||
|Ann Baxter|||Associate Non-executive
Director||||||
|Neil Schneider|||Associate Non-executive
Director||||||
|Undsey Robertson|||Director of Nursing,
Paffent Safety|and Quality|from 1st September|||2020|
|The Executive|Directors|and Non-executive
Directors ofthe Foundation
Trust Board are|||the Trustee ofthe Charity.||||
|The Executive|Directors|are appointed|by the
Non-executive
Directors|and the Governors||appoint|the|Non-|
|executive Directors.|||||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||~E*|cht|coo|
|---|---|---|---|---|---|
|Lucera Bronchoscope||||27||
|Mini Probe||||5||
|Oefibriltator||||6||
|Motomed
Muvi active Exercise plus||||7||
|Innaspire
deluxe reusable sidestream||& kit||5||
|MSK Ultrasound|system|||17||
|Accuvein||||5||
|Fluent System||||27||
|Hysterscope||||25||
|Other medical equipment||||||
|||||143||
##
##
|ajor refurbishments|and IT equipm|ent
purchases
during the year ar|e shown
below:||
|---|---|---|---|---|
||||~EDD|EDDD|
|Vocera volunteers|communication|badges and chargers|9||
|48x Dementia
Touch screen tablets|||12||
|LED Ceiling Mural|||8||
|Other refurbishment|costs||||
||||38||
##
|erate|d
char|itable fun|ds in|come will support
patient car|e and benefits, staff health and wellbeing.|
|---|---|---|---|---|---|
||||||~EditlEOOD|
|Staff|loNeiy|winnings|paid|||
|Staff|loNery|administration||costs||
||||||12|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Statement of Financia|l Ac|tivities for the y|ear ended|31 March 2021||||
|---|---|---|---|---|---|---|---|
|||||||Total|Total|
||||Note|Unrestricted|Reslrlrsed|Funds|Funds|
|||||Funds|Funds|2020/21|2019/2D|
|||||f000|f000|f000|fOOD|
|Income and endowments||from:||||||
|Donations|||3|440|107|547|341|
|Legacies|||3||16|16|118|
|Charitable
activities|||4||20|20|15|
|Other trading activities-staff||lottery|5||17|17||
|Other incoming
resources|||6|61|5|66|100|
|Investment
Income|||13.3|14|26|40|39|
|Total incoming resources||||515|191|706|6'I3|
|Expenditure
on:||||||||
|Raising Funds|||||12|12||
|Charitable
activities:||||||||
|Research Posts and Clinical||Care|||29|29|72|
|Purchase ofEquipment||||69|74|143|60|
|Refurbishment
costs||||9|29|38|80|
|Stafl Education
and Welfare||||160|18|178|62|
|Patient Welfare||||1|9|10|37|
|Governance
Costs|||10|13|24|37|35|
|Total expenditure
Net gain/(losses)
on investments|||13.1|252
84|195
149|233|~3|
|Net income/(expenditure)|before transfers|||347|145|492|230|
|Transfers between
funds|||16|2|(2)|||
|Net movement
in funds|||18|349|143|492|23D|
|Fund balances
brought|forward at 1 April||||1,087|1,554|1,324|
|Fund balances carried|forward at 31 March|||816|1,23D|2,046|1,554|
##
##
|||Note|Unrestricted|Restricted|Total at31|Total at 31|
|---|---|---|---|---|---|---|
||||Funds|Funds|March 2021|March 2020|
||||FOOD|5000|8000|8000|
|Fixed Assets|||||||
|Investments||13|551|BDO|1,351|1 113|
|Total fixed assets|||551|800|1,351|1,118|
|Current Assets|||||||
|Debtors and accrued income||14|250|30|280|14|
|Cash and cash equivalents|||67|453|520|455|
|Total current assets|||317|483|800|469|
|Current
liabilities|||||||
|Creditors: Amounts|falling due||||||
|within one year||15|52|53|105|33|
|Net current assets|||265|430|695|436|
|Total assets less current liabilities|||816|1,230|2,046|1,554|
|Net Assets|||816|1,230|2,046|1,554|
|The funds ofthe charity|||||||
|Restricted
income funds||||1,230|1,230|1,087|
|Unrestricted
income|funds||816||816|467|
|Total Charity Funds||19|816|1,230|2,046|1,554|
##
##
||||||Note|||
|---|---|---|---|---|---|---|---|
|||||||2020I21|2019I20|
|||||||2000|5000|
|Cash flows from operating||activities:||||||
|Net cash used in operating||acflvifles|||18|25|222|
|Cash flows from investing||activities:||||||
|Dividends|and interest from|investments|||13.3|40|39|
|Proceeds|from sale of investments|||||||
|Net cash|provided
by investing
activities|||||40|39|
|Change|in cash and cash|equivalents|in the reporting||period|65|261|
|Increase|in cash and cash equivalents||in lhe year|||65|261|
|Cash and|cash equivalents|at the beginning||of||||
|reporting|period|||||455|194|
|Total cash and cash equivalents
at the end||||||520|455|
|ofthe year||||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Payments|to|Receilpts from|Receilpts from|Amounts|owed|Amounts|due|
|---|---|---|---|---|---|---|---|---|---|
|||related parties||related|parties|to related|parties|from related||
|||||||||parties||
|||EOOO|||f000||f000||FOOD|
|Declaration of Interest||||||||||
|2020/21||||||||||
|Optimus|Health|Ltd|||||||250|
|NTH Solutions||LLP||||||||
|2019/20||||||||||
|Optimus|Health|Ltd|||175|||||
|NTH Solutions||LLP||||||||
|Optimus|Health|Ltd||||||||
|(Trading|Company|for North Tees and Harilepool|NHS|Foundation|Trust)|||||
##
##
||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||Funds|Funds|2020/21|2019/20|
||||ROOD|FOOD|RDOO|RODO|
|Donations|||2|79|81|135|
|Fundraising|Income Generated|by Donors|11|19|30|8|
|Grants Receivable|||173||173||
|Corporate|Donations||250|7|257|194|
|GIR Aid|||4|2|6|4|
|Legacies||||16|16|1'I8|
|Total||||123|663||
##
|The income|was pri|marily
from the prov|ision oftraining courses|in furtherance
oft|he Charity's
obje|ctives.|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||Funds|Funds|2020/21|2019/20|
||||FOOD|ROOD|ROOD|RDDD|
|Income from|the provision||||||
|ofeducation|and training|||20|20|15|
|Total||||20|20|15|
|5.Other Trading Activities|||||||
||||Unrestricted|Restricted|Total|Total|
||||Funds|Funds|2020/21|2019/20|
||||FOOD|FOOD|ROOD|ROOD|
|Staff Lotlery|deductions|||17|17||
|Total||||17|17||
|6. Other incoming||Resources|||||
||||Unrestricted|Restricted|Total|Total|
||||Funds|Funds|2020/21|2019/20|
||||ROOD|ROOD|FOOD|FODO|
|Other Income|||61|5|66|100|
|Total|||61|5|66|100|
##
##
|||||2020/21|2019/20|
|---|---|---|---|---|---|
|||||EOOO|EOOO|
|Staff|Lottery|Winnings|&Admin|12||
|Total||||12||
##
|||2020/21|2019/20|
|---|---|---|---|
|||EOOO|EOOO|
|Purchase of Equipment||143|60|
|Research Posts|and Clinical Care|29|72|
|Refurbishment
Costs & IT Equipment||38|80|
|Staff Education|and Welfare|178|62|
|Patients Welfare||10|37|
|Total||398|311|
##
##
##
##
##
|The investment
is v|The investment
is v|alued at bid|alued at bid|alued at bid|price 2020/21.|||
|---|---|---|---|---|---|---|---|
|13.1 Movement
In||fixed asset|||investment|2020/21|2019/20|
|||||||Total|Total|
|||||||6000|8000|
|Market value|brought||forward|||1,118|1,155|
|Monies owed|by CCLA for|||Charities||10|10|
|Short tenn dividends||||||(10)|(10)|
|Less disposals at carrying||||value||||
|Net (loss)/gain|on revaluation|||||233||
|Market value|at 31|March||||1,351|1,118|
|13.2 Market value at|||31 March|||2020/21|2019/2D|
|||||||Total|Total|
|||||||8000|F.ODD|
|Held In UK||||||||
|COIF Charities
Investment||||Fund||1,351|1,118|
|Total||||||1,351|1,118|
|The COIF Charities||Investment|||Fund includes the following|investments:||
|||||||2020/21|2019/20|
|Asset allocation||||||||
|Ovemeas
Equities||||||67.23%|80.21%|
|UK Equities||||||9.S9%|12.60%|
|Infrastructure|&Operating|||Assets||9.12%|968%|
|Cash &near cash||||||4.83%|620%|
|Property||||||3.90%|5.37%|
|Contractual
8|Other|Income||||268%|3.25%|
|Private Equity|8 Other|||||2.01%|2.15%|
|Fixed Interest||||||0.34%|0.54%|
##
|13.3 Total gross Income from inves|tments
and cash on deposit||
|---|---|---|
||2020/21|2019/20|
||Total|Total|
||EOOO|EOOO|
|Held in UK|||
|Investments||39|
|Total|40|39|
##
|Debtors|under|one|year|2020/21|2019/20|
|---|---|---|---|---|---|
|||||Total|Total|
|||||f000|EOOO|
|Dividend|Income|||10|10|
|Prepayments||||4|4|
|Accrued|Income|||266||
|Total||||260|14|
##
|Creditors|under one year|under one year||2020/21|2020/21|2019/20|
|---|---|---|---|---|---|---|
||||||Total|Total|
||||||EOOO|E000|
|Accruals|||||64|'I9|
|Deferred|Income||||9|9|
|Amounts|owed|to North Tees and|Hartlepool|NHS|32|5|
|Foundation
Trust|||||||
|Total|||||105||
|There is no security for non-trading|||amounts|owed to the Foundation|Trust.||
|16. Transfers||between funds||2020/21||2019/20|
||||||Total|Total|
||||||f000|EOOO|
|Transfers|||||||
##
##
##
##
##
|||||2020/21|2019/20|
|---|---|---|---|---|---|
|||||Total|Total|
|||||5000|5000|
|Net movement
in funds||||492|230|
|(Gain)/Loss
on investments||||(233)|37|
|Deduct interest/dividends||income shown||||
|in investing
activities||||(40)|(39)|
|(Increase)/ Decrease|in debtors|||(266)|(3)|
|Increase/(Decrease)|in creditors|||72|(3)|
|Net cash generated|from|operating|activities|25|222|
##
|19.Analysis o|fC|hadta|bl|e
Funds|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||Fund Balances|Incoming|Resources|Internal|Fund Balances|
|||||||||at 31March 2020|Resources|Expended|Transfers|al 31March 2021|
|flame||||Deva//pr/cn
ofthe nature end purpose|cfthe fund|||&000|2000|&000|ROOD|EDOO|
|||||||||OVER &25,000||||OVER &25,000|
|||||To support
patient cere within the Directorate of|||||||||
|t Memorial
Fund|(Surgery||)|Surgery||||45||||51|
|||||To support patient care within breast||service|||||||
|2 Breast Surgery|Fund|||Indudlng
equipmenl
&training||||62||||75|
|||||To support patient care for individuals||requiring|||||||
|9 Spinal Fund||||treabnent
vnthln
the Spinal Deparlmenl||||47||||48|
|||||To support
patient care fcr individuals||with blood|||||||
|4 Haematclogy
Fund||||disorders||||113|21|(10)||124|
|||||To support
patlenl care for individuals||diagnosed|||||||
|5 Urofogy Research Fund||||with Urology/Kidney
refsted IUness||||33||||38|
|a M Legacy Fund||||To support
the purchase
ofequipment
benefit ofcancer patients||for the||162|43|(52)||153|
|||||To supped
patient cere for Individuals||requirfng|||||||
|7 Cardiology
Fund
9 Neo-Natal||||treatment
within the Cardiac unit
Tosupport
patient care for Individuals
Ireatmenl
within the neo.natal unit||requiring||1DO
32|19|(3)
(9)||116
28|
|||||To support stroke patilenh
welfare and||staff|||||||
|9 Stroke Fund||||training
To support
Colorectal patient services.||staff||37|16|(10)||43|
|to Colorec!sl Cancer Fund||||EducaUon
&Training||||||(4)||30|
|11 Neonatal
Life Support||||Support
running cfLlfe Suppcrl coume||||28|18|(5)||41|
|||||Breast Cancer nurse training
/ Welfare||&|||||||
|r2 Sreast Care Nursing||Fund||hardship
fund fcrpatients||||||||88|
||||Tosupport
patient care for Individuals||requiring||||||||
|ts Chemotherapy
Fund|||treabnenlwUhln
Chemotherapy
Fund UHNT|||||49|21|(17)||53|
|Funds increased|toabove|||526,000as st 31Igarch 2021|||||||||
|Removed funds|decreased|||to below &25,DOD as at31&larch 2021|||||||||
|Funds at 31 March 202'I||||||||771|217|(122)||866|
|Other Funds balances||less|than &25000ss al 31stMarch 2021|||||316|123|(73)|(2)||
|Total Reslrl cled Funds||||||||1,097|34D|196|2|1,230|
|Totaf Unrestricted|Funds|||||||467|599|(252)||816|
|Total Fund balances at 31 Ii/larch 2D21||||||||1,654|939|447||2,046|
|fntemal Transfem|||Movement
between
restrldad
snd unrestricted||||funds||||||